KORU Medical Systems, Inc. (KRMD) financial statements and ratios from SEC XBRL: revenue $41.13M (TTM), net margin -6.4%, revenue growth 22.2% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $41.13M |
| Net Margin | -6.4% |
| Revenue Growth (YoY) | 22.2% |
| EPS Growth (YoY) | -53.8% |
| FCF Growth (YoY) | -70.9% |
| Price / Book | 8.36 |
| Price / Sales | 3.28 |
| FCF Yield | -0.8% |
| Altman Z-Score | 8.18 (safe) |
| Sector P/E (Healthcare) | 21.6 |
KRMD overview · KRMD earnings · KRMD KPIs · KRMD investor relations · KRMD ownership · KRMD peers · KRMD filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.